GL70 · 70 mg lyophilized vial
GLOW
BPC-157 · TB-500 · GHK-Cu
Our best-selling three-peptide co-formulation: BPC-157, TB-500 and GHK-Cu, co-lyophilized in a single 70 mg research vial. Synthesized in cGMP facilities and released with lot-specific documentation from an independent U.S. laboratory. Catalog purity specification ≥99.2% per component (HPLC).
GLOW is a co-lyophilized research preparation of BPC-157 (a synthetic pentadecapeptide), TB-500 (a synthetic thymosin beta-4 fragment), and GHK-Cu (a copper-binding tripeptide). In biochemical research settings these peptides are frequently investigated for their roles in copper transport mechanisms, actin-binding interactions, and peptide-mediated signaling pathways in vitro.
BPC-157 C62H98N16O22 (1,419.5 g/mol) · TB-500 C212H350N56O78S (4,963 g/mol) · GHK-Cu C14H23CuN6O4 (340.38 g/mol)
$139.99
Shop GLOW
View KLOW
What is GLOW peptide?
GLOW lot certificates
GLOW capsules
KL80 · 80 mg lyophilized vial
KLOW
KPV · GHK-Cu · BPC-157 · TB-500
Our four-component co-formulation: KPV, GHK-Cu, BPC-157 and TB-500, co-lyophilized in a single 80 mg research vial. Synthesized in cGMP facilities and released with lot-specific documentation from an independent U.S. laboratory. Catalog purity specification ≥99.2% per component (HPLC).
KLOW is a co-lyophilized research preparation of KPV (a lysine-proline-valine tripeptide), GHK-Cu (a copper-binding tripeptide), BPC-157 (a synthetic pentadecapeptide), and TB-500 (a synthetic thymosin beta-4 fragment). It carries the same three peptides as GLOW with the addition of KPV, investigated in vitro for copper transport mechanisms, melanocortin fragment signaling, and peptide-mediated signaling pathways.
KPV C16H30N4O4 (342.4 g/mol) · GHK-Cu C14H23CuN6O4 (340.38 g/mol) · BPC-157 C62H98N16O22 (1,419.5 g/mol) · TB-500 C212H350N56O78S (4,963 g/mol)
$169.99
Shop KLOW
View GLOW
What is KLOW peptide?
KLOW lot certificates
KLOW capsules